市场调查报告书
商品编码
1298836
2023-2028年按产品、适应症、分销渠道和地区分類的马匹保健市场Equine Healthcare Market by Product, Indication, Distribution Channel, and Region 2023-2028 |
2022年,全球马匹保健市场规模达到14.3亿美元。展望未来,IMARC集团预计,到2028年,市场规模将达到20.7亿美元,在2023-2028年期间表现出6.60%的增长率(CAGR)。马匹数量的迅速增加,马主对马匹健康和适当营养的认识不断提高,以及对先进成像技术的利用,代表了推动市场发展的一些关键因素。
马匹保健是兽医的一个分支,主要是对马匹疾病的诊断、治疗和预防。它涉及到各种产品的使用,如疫苗、驱虫剂、局部治疗、关节补充剂、益生菌、苍蝇喷雾剂、蹄部护理剂、防腐剂和性能添加剂。马匹保健包括预防护理、疾病管理、跛行治疗、生殖护理、口腔卫生、康复和解决行为问题。它有助于改善整体健康状况,预防未来的并发症,允许早期疾病检测,促进成功繁殖,促进延长寿命,并减少严重疾病的风险,如跛行、牙齿问题、感染、肥胖、疱疹和狂犬病。
由于马匹被广泛用于比赛、养殖和作为伴侣,马匹数量迅速增加是推动市场增长的主要因素之一。马匹保健服务和产品,如预防保健、生殖服务、康复中心、疫苗和保健品,被广泛用于确保最佳性能、预防并发症、保护免受伤害和减少疾病风险。除此之外,马主对马匹健康和适当营养重要性的认识不断提高,成为另一个增长的诱导因素。此外,政府采取各种措施支持动物福利,促进负责任的所有权,并提供高质量的医疗设施,对市场增长产生了积极的影响。此外,利用先进的成像技术,如数字射线照相术、超声波和内窥镜,提供马体的详细截面图像,从而可以诊断肌肉骨骼损伤、跛行和内部疾病,这也促进了市场的增长。除此之外,最近开发的马匹可穿戴健康监测设备,可以连续监测生命体征、活动水平和行为,以便及早发现任何健康问题,为市场增长提供动力。此外,越来越多的马术运动,如赛马、跳马、盛装舞步和耐力赛,正在推动市场增长。其他因素,包括消费者支出能力的提高,新兴的宠物人性化趋势,广泛的研究和开发(R&D)活动,以及电子商务行业的快速扩张,预计将推动市场增长。
请注意,这只代表部分公司的名单,完整的名单已在报告中提供。
The global equine healthcare market size reached US$ 1.43 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.07 Billion by 2028, exhibiting a growth rate (CAGR) of 6.60% during 2023-2028. The rapid increase in the equine population, rising awareness among owners regarding equine health and proper nutrition, and the utilization of advanced imaging techniques represent some of the key factors driving the market.
Equine healthcare is a branch of veterinary medicine that focuses on the diagnosis, treatment, and prevention of diseases in horses. It involves the utilization of various products, such as vaccines, dewormers, topical treatments, joint supplements, prebiotics, fly sprays, hoof conditioners, antiseptics, and performance additives. Equine healthcare includes preventive care, illness management, lameness treatment, reproductive care, oral hygiene, rehabilitation, and addressing behavioral issues. It assists in improving overall health, preventing future complications, allowing early disease detection, facilitating successful breeding, promoting a longer lifespan, and reducing the risk of serious diseases, such as lameness, dental problems, infections, obesity, herpes, and rabies.
The rapid increase in the equine population due to the widespread utilization of horses in racing, farming, and as companions is one of the primary factors propelling the market growth. Equine healthcare services and products, such as preventive care, reproductive services, rehabilitation centers, vaccines, and health supplements, are widely used to ensure optimum performance, prevent complications, protect from injuries, and reduce the risk of illnesses. In addition to this, rising awareness among the owners regarding the importance of equine health and proper nutrition is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to support animal welfare, promote responsible ownership, and provide access to high-quality healthcare facilities is positively influencing the market growth. Additionally, the utilization of advanced imaging techniques, such as digital radiography, ultrasound, and endoscopy, to provide detailed cross-sectional images of the horse's body, thus allowing the diagnosis of musculoskeletal injuries, lameness, and internal diseases, is contributing to the market growth. Besides this, the recent development of wearable health monitoring devices for horses, which allows continuous monitoring of vital signs, activity levels, and behavior to facilitate early detection of any health issues, is providing an impetus to the market growth. Moreover, the growing number of equine sports, such as racing, jumping, dressage, and endurance riding, is propelling the market growth. Other factors, including rising expenditure capacities of consumers, emerging trends of pet humanization, extensive research and development (R&D) activities, and rapid expansion of the e-commerce industry, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global equine healthcare market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product, indication, and distribution channel.
Drugs
Anti-Inflammatory Drugs
Parasiticide Drugs
Others
Vaccines
Live Attenuated Vaccine
Recombinant Vaccine
Others
Medicated Feed Additives
Diagnostics
Others
The report has provided a detailed breakup and analysis of the equine healthcare market based on the product. This includes drugs (anti-inflammatory drugs, parasiticide drugs, and others), vaccines (live attenuated vaccine, recombinant vaccine, and others), medicated feed additives, diagnostics, and others. According to the report, drugs represented the largest segment.
Musculoskeletal Disorders
Parasite Control
Equine Herpes Virus
Equine Encephalomyelitis
Equine Influenza
West Nile Virus
Tetanus
Rabies
Others
A detailed breakup and analysis of the equine healthcare market based on the indication has also been provided in the report. This includes musculoskeletal disorders, parasite control, equine herpes virus, equine encephalomyelitis, equine influenza, West Nile virus, tetanus, rabies, and others. According to the report, parasite control accounted for the largest market share.
Veterinary Hospitals and Clinics
Retail Pharmacies and Drug Stores
A detailed breakup and analysis of the equine healthcare market based on the distribution channel has also been provided in the report. This includes veterinary hospitals and clinics and retail pharmacies and drug stores. According to the report, veterinary hospitals and clinics accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for equine healthcare. Some of the factors driving the North America equine healthcare market included the rising equine population, supportive government policies, and significant technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global equine healthcare market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Esaote SpA, Hallmarq Veterinary Imaging, IDEXX Laboratories Inc., Merck & Co. Inc., Vetoquinol S.A., Zoetis Inc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.